5 Key Takeaways
-
1
Approximately 30% of clinic patients evaluated had diabetic retinopathy, many with diabetic macular edema.
-
2
The prevalence of diabetes is increasing, leading to more vision-threatening complications from diabetic retinopathy.
-
3
Latest anti-VEGF treatments for diabetic retinopathy and diabetic macular edema include faricimab and aflibercept 8 mg.
-
4
Artificial intelligence is being discussed for DR screening, emphasizing validation and equitable performance across populations.
-
5
Accurate ICD-10 coding for diabetic eye disease is crucial for reflecting the complexity of care delivered.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
